• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高通量三重实时 PCR 用于新生儿严重原发性免疫缺陷病的筛查。

Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR.

机构信息

Division of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden.

出版信息

Blood. 2012 Mar 15;119(11):2552-5. doi: 10.1182/blood-2011-08-371021. Epub 2011 Nov 30.

DOI:10.1182/blood-2011-08-371021
PMID:22130802
Abstract

Severe combined immunodeficiency (SCID) and X-linked agammaglobulinemia (XLA) are inborn errors of immune function that require prompt diagnosis and treatment to prevent life-threatening infections. The lack of functional T or B lymphocytes in these diseases serves as a diagnostic criterion and can be applied to neonatal screening. A robust triplex PCR method for quantitation of T-cell receptor excision circles (TRECs) and κ-deleting recombination excision circles (KRECs), using a single Guthrie card punch, was developed and validated in a cohort of 2560 anonymized newborn screening cards and in 49 original stored Guthrie cards from patients diagnosed with SCID, XLA, ataxia-telangiectasia, Nijmegen-breakage-syndrome, common variable immunodeficiency, immunoglobulin A deficiency, or X-linked hyper-IgM syndrome. Simultaneous measurement of TREC and KREC copy numbers in Guthrie card samples readily identified patients with SCID, XLA, ataxia-telangiectasia and Nijmegen-breakage-syndrome and thus facilitates effective newborn screening for severe immunodeficiency syndromes characterized by the absence of T or B cells.

摘要

严重联合免疫缺陷(SCID)和 X 连锁无丙种球蛋白血症(XLA)是免疫功能的先天性缺陷,需要及时诊断和治疗,以预防危及生命的感染。这些疾病中缺乏功能性 T 或 B 淋巴细胞可作为诊断标准,并可应用于新生儿筛查。本研究开发并验证了一种使用单个 Guthrie 卡打孔进行 T 细胞受体切除环(TRECs)和 κ 缺失重组切除环(KRECs)定量的三重 PCR 方法,该方法应用于 2560 张匿名新生儿筛查卡和 49 张原始储存的 Guthrie 卡,这些卡来自诊断为 SCID、XLA、共济失调毛细血管扩张症、范可尼贫血、普通可变免疫缺陷、免疫球蛋白 A 缺乏症或 X 连锁高 IgM 综合征的患者。在 Guthrie 卡样本中同时测量 TREC 和 KREC 拷贝数可轻松识别出 SCID、XLA、共济失调毛细血管扩张症和范可尼贫血患者,从而有助于有效地对以 T 或 B 细胞缺失为特征的严重免疫缺陷综合征进行新生儿筛查。

相似文献

1
Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR.高通量三重实时 PCR 用于新生儿严重原发性免疫缺陷病的筛查。
Blood. 2012 Mar 15;119(11):2552-5. doi: 10.1182/blood-2011-08-371021. Epub 2011 Nov 30.
2
Newborn screening for severe combined immunodeficiency: The results of the first pilot TREC and KREC study in Ukraine with involving of 10,350 neonates.新生儿严重联合免疫缺陷症筛查:乌克兰首次 TREC 和 KREC 研究(涉及 10350 名新生儿)结果。
Front Immunol. 2022 Sep 15;13:999664. doi: 10.3389/fimmu.2022.999664. eCollection 2022.
3
A high-throughput TREC- and KREC-based newborn screening for severe inborn errors of immunity.基于高通量TREC和KREC的严重先天性免疫缺陷新生儿筛查。
Pediatr Int. 2025 Jan-Dec;67(1):e15872. doi: 10.1111/ped.15872.
4
Newborn Screening for SCID and Other Severe Primary Immunodeficiency in the Polish-German Transborder Area: Experience From the First 14 Months of Collaboration.波兰-德国边境地区新生儿 SCID 和其他严重原发性免疫缺陷病的筛查:合作头 14 个月的经验。
Front Immunol. 2020 Oct 16;11:1948. doi: 10.3389/fimmu.2020.01948. eCollection 2020.
5
Prospective neonatal screening for severe T- and B-lymphocyte deficiencies in Seville.在塞维利亚对严重T淋巴细胞和B淋巴细胞缺陷进行前瞻性新生儿筛查。
Pediatr Allergy Immunol. 2016 Feb;27(1):70-7. doi: 10.1111/pai.12501. Epub 2015 Nov 23.
6
Newborn screening for severe T and B cell immunodeficiency in Israel: a pilot study.以色列新生儿严重T和B细胞免疫缺陷筛查:一项试点研究。
Isr Med Assoc J. 2013 Aug;15(8):404-9.
7
[A first pilot study on the neonatal screening of primary immunodeficiencies in Spain: TRECS and KRECS identify severe T- and B-cell lymphopenia].[西班牙原发性免疫缺陷新生儿筛查的首次试点研究:TRECS和KRECS可识别严重T细胞和B细胞淋巴细胞减少症]
An Pediatr (Barc). 2014 Nov;81(5):310-7. doi: 10.1016/j.anpedi.2014.08.002. Epub 2014 Sep 30.
8
Determining T and B Cell development by TREC/KREC analysis in primary immunodeficiency patients and healthy controls.通过 TRECs/KRECs 分析确定原发性免疫缺陷患者和健康对照者的 T 细胞和 B 细胞发育情况。
Scand J Immunol. 2022 Mar;95(3):e13130. doi: 10.1111/sji.13130. Epub 2022 Jan 3.
9
Comprehensive newborn screening for severe combined immunodeficiency, X-linked agammaglobulinemia, and spinal muscular atrophy: the Chinese experience.针对重症联合免疫缺陷、X连锁无丙种球蛋白血症和脊髓性肌萎缩症的新生儿综合筛查:中国经验
World J Pediatr. 2024 Dec;20(12):1270-1282. doi: 10.1007/s12519-024-00846-7. Epub 2024 Nov 5.
10
Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden-a 2-Year Pilot TREC and KREC Screening Study.瑞典严重原发性免疫缺陷病的新生儿筛查——一项为期两年的TREC和KREC筛查试点研究。
J Clin Immunol. 2017 Jan;37(1):51-60. doi: 10.1007/s10875-016-0347-5. Epub 2016 Nov 21.

引用本文的文献

1
T-Cell Receptor Excision Circle/Kappa-Deleting Recombination Excision Circle-Based Newborn Screening Program for Severe Combined Immunodeficiency in Kumamoto, Japan.日本熊本县基于T细胞受体切除环/κ链缺失重组切除环的重症联合免疫缺陷新生儿筛查项目
Cell Biochem Biophys. 2025 Sep 2. doi: 10.1007/s12013-025-01873-5.
2
Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early Diagnosis.无丙种球蛋白血症的自我报告临床结局和生活质量:早期诊断的重要性
J Clin Immunol. 2025 Aug 25;45(1):125. doi: 10.1007/s10875-025-01904-z.
3
Utility of simultaneous quantification of TREC/KREC in patients with common variable immunodeficiency phenotype: an observational study from North India.
常见可变免疫缺陷表型患者中TREC/KREC同步定量的效用:一项来自印度北部的观察性研究
Immunol Res. 2025 Mar 17;73(1):63. doi: 10.1007/s12026-025-09615-8.
4
Newborn screening for SCID: the very first prospective pilot study from Türkiye.新生儿 SCID 筛查:来自土耳其的首个前瞻性试点研究。
Front Immunol. 2024 Oct 2;15:1384195. doi: 10.3389/fimmu.2024.1384195. eCollection 2024.
5
A Non-targeted Proteomics Newborn Screening Platform for Inborn Errors of Immunity.针对免疫性先天缺陷的非靶向蛋白质组学新生儿筛查平台。
J Clin Immunol. 2024 Oct 25;45(1):33. doi: 10.1007/s10875-024-01821-7.
6
Paving the way in implementation of SCID newborn screening in developing nations: feasibility study and strategies to move forward in Malaysia.在发展中国家实施 SCID 新生儿筛查的探索之路:马来西亚的可行性研究及推进策略。
Front Immunol. 2024 Jun 25;15:1400247. doi: 10.3389/fimmu.2024.1400247. eCollection 2024.
7
Quality considerations and major pitfalls for high throughput DNA-based newborn screening for severe combined immunodeficiency and spinal muscular atrophy.高通量 DNA 新生儿筛查严重联合免疫缺陷病和脊髓性肌萎缩症的质量考虑因素和主要陷阱。
PLoS One. 2024 Jun 28;19(6):e0306329. doi: 10.1371/journal.pone.0306329. eCollection 2024.
8
Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia.造血干细胞基因编辑可挽救 X 连锁无丙种球蛋白血症的 B 细胞发育障碍。
J Allergy Clin Immunol. 2024 Jul;154(1):195-208.e8. doi: 10.1016/j.jaci.2024.03.003. Epub 2024 Mar 11.
9
Purine Nucleoside Phosphorylase Deficiency in Two Unrelated Patients with Autoimmune Hemolytic Anemia and Eosinophilia: Two Novel Mutations.两名患有自身免疫性溶血性贫血和嗜酸性粒细胞增多症的无关患者中的嘌呤核苷磷酸化酶缺乏症:两种新突变
Arch Iran Med. 2023 Dec 1;26(12):712-716. doi: 10.34172/aim.2023.105.
10
Clinical features and mutational analysis of X-linked agammaglobulinemia patients in Malaysia.马来西亚 X 连锁无丙种球蛋白血症患者的临床特征和基因突变分析。
Front Immunol. 2023 Sep 22;14:1252765. doi: 10.3389/fimmu.2023.1252765. eCollection 2023.